Available to SourceHuman Prescription DrugOncology & Specialty

Gomekli (Mirdametinib)

1 mg/1 · Tablet For Suspension

By SpringWorks Therapeutics, Inc.

Mirdametinib · Tablet, For Suspension · 1 mg

NDC: 82448-134
Route: Oral
Therapeutic class: Kinase Inhibitor , Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA], Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
Marketing category: NDA

Package sizes

42 TABLET, FOR SUSPENSION in 1 BOTTLE (82448-134-42)NDC 82448-134-42Available to Order
84 TABLET, FOR SUSPENSION in 1 BOTTLE (82448-134-84)NDC 82448-134-84Available to Order

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Oncology & Specialty

See all →

Gomekli (Mirdametinib)

Package sizes

Additional information

Request this medication.

Related in Oncology & Specialty

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)